Fifth major deal for Unilife injectables
Injectable device manufacturer Unilife has announced a contract with a pharmaceutical multinational for the use of its Ocu-ject eye syringe, marking its fifth major contract in four months.
Archives for January 6, 2014
Plan to lease Doxil space at Ben Venue to J&J needs approval says BI
Boehringer Ingelheim (BI) has warned that latest efforts to ensure continued Doxil production at Ben Venue's troubled sterile injectables plant in Bedford, Ohio must still be approved.
US FDA 483 and 23 observations for Hospira's troubled Indian plant
A Hospira plant in India that was issued with a US FDA warning letter last summer has been criticised by the agency again following an inspection last month.
Heparin consolidation: Hepalink to buy SPL for $337m
Chinese API firm Shenzhen Hepalink has announced plans to buy Scientific Protein Laboratories (SPL) from private equity investor American Capital for $337.5m.
New China GMP regs stop Hep B vacc firm restarting production
New GMP rules mean Kangtai Biological Products cannot restart production of a Hepatitis B vaccine wrongly linked to deaths even though authorities now deem it to be safe.